Growth-factor Enhanced Matrix (β-TCP/rhPDGF-BB)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameGrowth-factor Enhanced Matrix (β-TCP/rhPDGF-BB)
Drug Alias NameGEM-21S
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionPlatelet-derived growth factor receptor agonistsOsteogenesis stimulants
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsPeriodontal DiseasesBone Diseases
Global Approved IndicationsBone Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2007/01/01
Country/TerritoryCanadaMexicoEgypt
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLynch Biologics LlcUniversidad Autonoma de Nuevo LeonZymogenetics Inc
Inactive CompaniesTanta University
Active IndicationsPeriodontal DiseasesBone Diseases
Inactive IndicationsN/A

Other Information

ATC CodeM05
Related LinksN/A